Aldosterone and Diabetic Cardiovascular Disease: Research and Mentoring Progam
醛固酮和糖尿病心血管疾病:研究和指导计划
基本信息
- 批准号:8261917
- 负责人:
- 金额:$ 20.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-02 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdenosineAlbuminuriaAldosteroneAngiotensin IIAngiotensin II ReceptorAngiotensin-Converting Enzyme InhibitorsAnimalsApplications GrantsAreaBlood PressureBlood VesselsBlood flowCardiacCardiovascular systemChronicClinical DataClinical InvestigatorClinical ResearchCoronaryCorticotropinDataDiabetes MellitusDouble-Blind MethodEchocardiographyEducational process of instructingEnalaprilEnzyme InhibitionFunctional disorderFundingGenerationsGoalsGrantHealthHeartHeart DiseasesHeart failureHormonesHydrochlorothiazideHypertensionImageIn VitroIndividualInflammatoryInjuryInvestigationKidneyKidney FailureLeadLeftMediator of activation proteinMentorsMineralocorticoid ReceptorMorbidity - disease rateMusMyocardialMyocardial perfusionNon-Insulin-Dependent Diabetes MellitusObesityPatientsPeptidyl-Dipeptidase APerfusionPhysiciansPlacebosPositron-Emission TomographyPotassiumRandomizedReceptor ActivationRenal CirculationRenal Plasma FlowRenal functionResearchResearch PersonnelRestRodentRoleSpironolactoneStressStrokeTestingTimeTissuesTrainingTraining SupportVascular DiseasesVentricularWorkcardiovascular injurychemokinecytokinedb/db mousediabeticdiabetic cardiomyopathyeffective therapyeplerenoneheart circulationheart functionimprovedimproved functioninginterestkidney vascular structuremortalitymultidisciplinarypatient orientedpatient oriented researchpre-clinicalpreclinical studyprospectivepublic health relevanceresponsevascular inflammationvasoactive agent
项目摘要
DESCRIPTION (provided by applicant): ABSTRACT This K24 application is to provide support for protected time for: 1) mentoring/teaching of junior clinical investigators; and 2) patient-oriented research investigating the role of aldosterone in the pathophysiology of diabetic cardiovascular disease. Recent data provide support for the hypothesis that activation of the mineralocorticoid receptor (MR) contributes to diabetic vascular injury, though the mechanisms are uncertain. Consistent with this hypothesis, our pre-clinical studies demonstrate that blockade of MR reduces renal injury in diabetic db/db mice and reduces vascular inflammation and cardiac and renal injury in hypertensive, angiotensin II (ANGII)-infused rodents. Our clinical studies show that short-term treatment with the MR antagonist eplerenone improves coronary circulatory function as compared to treatment with hydrochlorothiazide (HCTZ) in subjects with diabetes receiving angiotensin-converting enzyme (ACE) inhibition therapy. This observation could not be attributed to blood pressure changes suggesting that MR antagonists are not working via a classical renal effect, but via an additional, volume control-independent mechanism. This proposal tests the hypotheses that MR activation contributes to progression of vascular disease in subjects with type 2 diabetes mellitus (T2DM) receiving ACE inhibitor therapy, and consequently, MR antagonists exert beneficial effects by reducing vascular dysfunction and injury, inhibiting ANGII vascular effects, improving coronary circulatory and cardiac function and improving renovascular function. To address these hypotheses we will perform a prospective double-blind study in subjects with T2DM and hypertension receiving chronic ACE inhibitor therapy randomized to one of three treatments: 1) MR antagonist spironolactone; 2) HCTZ plus potassium; and 3) placebo. These studies provide a fertile area for investigation by trainees interested in patient-oriented research and will provide new information about the mechanisms by which MR antagonists reduce diabetic cardiovascular injury, with the goal of introducing new, effective treatments of cardiovascular injury in individuals with diabetes.
PUBLIC HEALTH RELEVANCE: PROJECT NARRATIVE This grant application seeks support for the training and mentoring of a new generation of physicians and investigators interested in performing research in patients with diabetes and heart disease. Diabetes causes injury to blood vessels. This injury leads to many health problems including heart disease, kidney failure and stroke. The goal of this research is to determine whether blocking the actions of a hormone known as aldosterone improves the function of vessels in the hearts and kidneys of patients with type 2 diabetes and whether this leads to improvements in heart and kidney function. Thus, this research may lead to new treatments for patients with diabetes and injury to their hearts and kidneys, and will provide a forum for mentoring trainees in patient-oriented research.
描述(由申请人提供):摘要本K24申请旨在为以下受保护的时间提供支持:1)指导/教学初级临床研究者; 2)调查醛固酮在糖尿病心血管疾病病理生理学中的作用的以患者为导向的研究。最近的数据提供了支持的假设,盐皮质激素受体(MR)的激活有助于糖尿病血管损伤,虽然机制是不确定的。与这一假设一致,我们的临床前研究表明,阻断MR可减少糖尿病db/db小鼠的肾损伤,并减少高血压血管紧张素II(ANGII)输注啮齿动物的血管炎症和心脏及肾损伤。我们的临床研究表明,在接受血管紧张素转换酶(ACE)抑制治疗的糖尿病受试者中,与氢氯噻嗪(HCTZ)治疗相比,MR拮抗剂依普利酮短期治疗可改善冠状动脉循环功能。该观察结果不能归因于血压变化,表明MR拮抗剂不是通过经典的肾脏效应发挥作用,而是通过额外的非容量控制依赖性机制发挥作用。该提案检验了以下假设:MR激活有助于接受ACE抑制剂治疗的2型糖尿病(T2 DM)受试者的血管疾病进展,因此,MR拮抗剂通过减少血管功能障碍和损伤、抑制ANGII血管效应、改善冠状动脉循环和心脏功能以及改善肾血管功能发挥有益作用。为了解决这些假设,我们将在接受长期ACE抑制剂治疗的T2 DM和高血压受试者中进行一项前瞻性双盲研究,这些受试者随机接受以下三种治疗之一:1)MR拮抗剂螺内酯; 2)HCTZ+钾; 3)安慰剂。这些研究提供了一个肥沃的领域调查感兴趣的学员以患者为导向的研究,并将提供新的信息的机制,MR拮抗剂减少糖尿病心血管损伤,目的是引入新的,有效的治疗糖尿病患者心血管损伤。
公共卫生关系:该拨款申请旨在支持对糖尿病和心脏病患者进行研究感兴趣的新一代医生和研究人员的培训和指导。糖尿病导致血管损伤。这种损伤会导致许多健康问题,包括心脏病、肾衰竭和中风。这项研究的目的是确定阻断一种称为醛固酮的激素的作用是否能改善2型糖尿病患者心脏和肾脏的血管功能,以及这是否能改善心脏和肾脏功能。因此,这项研究可能会为糖尿病患者及其心脏和肾脏损伤带来新的治疗方法,并将为指导以患者为导向的研究的学员提供论坛。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gail Kurr Adler其他文献
Gail Kurr Adler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gail Kurr Adler', 18)}}的其他基金
Mineralocorticoid receptor, coronary microvascular function, and cardiac efficiency in hypertension
盐皮质激素受体、冠状动脉微血管功能和高血压患者的心脏效率
- 批准号:
10586784 - 财政年份:2023
- 资助金额:
$ 20.07万 - 项目类别:
The Functional Neuroanatomy of the Human Physiological Stress Response
人类生理应激反应的功能神经解剖学
- 批准号:
10609821 - 财政年份:2019
- 资助金额:
$ 20.07万 - 项目类别:
The functional neuroanatomy of the human physiological stress response
人类生理应激反应的功能神经解剖学
- 批准号:
9924682 - 财政年份:2019
- 资助金额:
$ 20.07万 - 项目类别:
The functional neuroanatomy of the human physiological stress response
人类生理应激反应的功能神经解剖学
- 批准号:
10394222 - 财政年份:2019
- 资助金额:
$ 20.07万 - 项目类别:
Aldosterone and Cardiovascular Disease: Research and Mentoring Program
醛固酮和心血管疾病:研究和指导计划
- 批准号:
9456791 - 财政年份:2011
- 资助金额:
$ 20.07万 - 项目类别:
Aldosterone and Diabetic Cardiovascular Disease: Research and Mentoring Progam
醛固酮和糖尿病心血管疾病:研究和指导计划
- 批准号:
8661245 - 财政年份:2011
- 资助金额:
$ 20.07万 - 项目类别:
Aldosterone and Cardiovascular Disease: Research and Mentoring Program
醛固酮和心血管疾病:研究和指导计划
- 批准号:
9314760 - 财政年份:2011
- 资助金额:
$ 20.07万 - 项目类别:
Aldosterone and Cardiovascular Disease: Research and Mentoring Program
醛固酮和心血管疾病:研究和指导计划
- 批准号:
10155549 - 财政年份:2011
- 资助金额:
$ 20.07万 - 项目类别:
Aldosterone and Diabetic Cardiovascular Disease: Research and Mentoring Progam
醛固酮和糖尿病心血管疾病:研究和指导计划
- 批准号:
8462676 - 财政年份:2011
- 资助金额:
$ 20.07万 - 项目类别:
Aldosterone and Diabetic Cardiovascular Disease: Research and Mentoring Progam
醛固酮和糖尿病心血管疾病:研究和指导计划
- 批准号:
8112135 - 财政年份:2011
- 资助金额:
$ 20.07万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 20.07万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 20.07万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 20.07万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 20.07万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 20.07万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 20.07万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 20.07万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 20.07万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 20.07万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 20.07万 - 项目类别:
Research Grant